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Mechanism of impaired urinary concentration in chronic primary
glomerulonephritls. To define the role of medullary damage and the
influence of solute load and blood pressure (BP) in impairing urinary
concentration, patients with chronic glomerulonephritis were investi-
gated by histological and functional studies. In 59 biopsy specimens, the
degree of medullary fibrosis was correlated inversely with urinary
specific gravity and was significantly greater in hypertensive than in
normotensive subjects. The following clearance studies were carried
out in patients with a GFR of 15 to 40 ml/min in maximal antidiuresis:
(1) Eight patients were studied while receiving a high sodium and
protein diet and then after 1 week of low sodium, low protein diet; (2)
ten patients were loaded with hypertonic saline (3%) to increase urine
volume up to 25 to 30% of GFR; (3) the concentrating ability was
compared in 15 normotensives and 15 hypertensives with comparable
GFR; (4) the concentrating ability was studied in nine hypertensive
patients before and after drug-induced normalization of BP. In (1) no
change occurred in maximal urine osmolality (Uosm) even if fractional
sodium excretion and filtered load of urea were reduced. In (2), values
of Uo,m fell below those of plasma osmolality. In (3), Uosm and negative
free-water generation were lower in hypertensive than in normotensive
subjects. In (4), normalization of BP was not associated with any
change in Uø,m. These results indicate that osmotic diuresis does not
play a critical role in reducing urinary concentration. This defect is
better accounted for by an intrinsic medullary damage, enhanced in
hypertensive patients, which may impair the permeability of collecting
ducts to water.
Mécanisme de l'altération de Ia concentration urinaire au cours des
glomerulonephrites chroniques primitives. Afin de définir le rOle des
alterations médullaires et de l'influence de la charge en solutés et de Ia
pression sanguine (BP) dans Ic défaut de concentration urinaire, des
malades atteints de glomerulonephrite chronique ont dté explores par
des etudes histologiques et fonctionnelles. Dans 59 biopsies, le degrC de
fibrose médullaire était inversement corrClé a Ia densité specifique
urinaire, et était significativement plus important chez les hypertendus
que chez les normaux tendus. Les etudes de clearance suivantes ont eté
entreprises chez des malades dont GFR était de 15—40 mllmin en
antidiurése maximale: (1) huit malades ont été étudids alors qu'ils
recevaient un régime riche en sodium et en protides, puis aprés une
semaine de régime pauvre en sodium et pauvre en protides; (2) dix
malades ont recu une surcharge de solute sale hypertonique; (3) la
capacitd de concentration a Cté comparCe chez 15 normotendus et 15
hypertendus a GFR comparable; (4) la capacité de concentration a étd
étudide chez 9 hypertendus avant et après normalisation médicamen-
teuse de la BP. Chez (I), aucune modification de l'osmolalité urinaire
maximale (Uosm) ne s'est produite, méme si l'excrétion fractionnelle du
sodium et Ia charge ureique filtrée étaient rCduites. Chez (2), les valeurs
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de Uo,m ont chute en dessous de celles de l'osmolalitC plasmatique.
Chez (3), IJ0, et la gCnération d'eau libre negative étaient moindres
chez les hypertendus que chez les normotendus. Chez (4), la normalisa-
tion de BP n'était associée a aucune modification de Uosm. Ces résultats
indiquent qu'une diurése osmotique nejoue pas de rOle critique dans la
reduction de Ia concentration urinaire. Ce défaut est mieux expliqué par
une perturbation médullaire intrinseque, accrue chez les hypertendus,
qui pourrait altérer Ia permeabilite des canaux collecteurs a l'eau.
The mechanisms responsible for the defective urinary con-
centration ability in patients with chronic renal failure have
been the object of extensive debate [1, 2]. Experimental models
in animals suggest that this defect is secondary to a functional
adaptation of residual nephrons to the uremic environment
[increased filtered load of solutes, expansion of extracellular
fluid volume (ECV), increase in blood pressure, and so forth]
[3—6]. The resulting increase in solute and water excretion
would impair the concentrating ability in a fashion quite similar
to that observed during solute diuresis in normal subjects [7].
Other studies [8, 91 indicate alterations of the tubular epithelium
and/or the medullary interstitium of the diseased kidney as the
culprit of reduced concentrating ability. Disproportionate de-
struction of long-looped nephrons, damage of tubular epi-
thelium, alteration in the rate and distribution of intrarenal
blood flow [10, 11] and distortion of medullary structures could
reduce interstitial hypertonicity and interfere with the concen-
trating mechanism.
The present study was therefore undertaken to clarify
whether intrarenal or extrarenal mechanisms are responsible
for the impaired urinary concentration observed in patients with
chronic renal failure due to primary glomerular diseases.
Methods
Patients. One hundred and twelve patients (67 males and 45
females), aged 14 to 69 years with primary glomerular disease
and renal function stationary in the last 3 months, were selected
from an outpatient population undergoing periodical follow-up
at the Nephrology Unit, University of Naples, Naples, Italy. In
88 patients a diagnosis of glomerulonephritis was established by
renal biopsy: Thirty patients had mesangial proliferative gb-
merulonephritis (GN); 20, membranoproliferative GN; 13, Ig
A-GN; 12, membranous GN; 9, focal glomerulosclerosis; 4,
minimal changes GN. In the other 24 patients the diagnosis of
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GN was based on anamnestic, clinical, and laboratory data. In
all patients, the absence of disorders causing secondary
nephropathies (that is, diabetes mellitus, lupus erithematosus,
cryoglobulinemia, paraproteinemia, lymphomas, vasculitis,
amyloidosis, and so forth) was assessed by adequate diagnostic
procedures including specific laboratory tests and, whenever
indicated, the biopsy of extrarenal tissue. In all patients
urography showed no sign of pyelonephritis or urinary obstruc-
tion. Finally, no patient had peripheral edema, congestive heart
failure, serum albumin less than 3 g%, salt-losing nephropathy,
urinary tract infection, clinically recognizable ECV depletion,
hypokalemia, or hypercalcemia. All the patients were hospital-
ized during the study and received a constant sodium intake of
100 mEq/day. Protein intake varied in single patients ranging
between 0.6 and 1.0 glkg of body wt in inverse relation with
GFR (0.6 glkg of body wt for 15 GFR < 20 mI/mm; 0.8 g/kg
of body wt for 20 GFR < 30 mI/mm; 1.0 g/kg of body wt for
30 GFR < 40 mllmin and for normal GFR). All patients were
without any medication for at least 2 weeks before the study.
The patients were classified as normotensive or hypertensive
according to a blood pressure (BP) lower or higher than 140/90
mm Hg, respectively.
Histological studies. Fifty-nine renal biopsy specimens con-
taining both medullary and cortical tissue were selected retro-
spectively from a group of 379 biopsy specimens performed in
patients with GN. Renal biopsy specimens had been fixed in
Bouin-Dubosq solution. Two-micron paraffin sections were
stained with hematoxylin-eosin, periodic acid Schiff, silver
methenamin, Masson's thrichrome, and Van Gieson. In these
biopsy specimens the degree of medullary fibrosis, interstitial
infiltration with inflammatory cells, and arteriolosclerosis was
estimated; the tubular damage (that is, tubular atrophy and
dilatation) was also identified. The alterations in medullary and
vasal structures were classified according to the score proposed
by Haggitt, Pitcok, and Muirhead [12]. The degree of inflam-
matory infiltration was graded as follows: grade 0, absence of
infiltration; grade 1, single infiltration; grade 2, multiple moder-
ate infiltration; grade 3, multiple intense infiltration. In 29 out of
59 renal biopsy specimens with medullary tissue, material for
direct immunofluorescence had been obtained and immediately
frozen; cryostat microtome sections had been processed for the
demonstration of IgG, 1gM, IgA, C3, C4, and fibrinogen with
fluorescein isothiocyanate-conjugated antisera. The histological
diagnosis of glomerular disease was attributed to mesangial
proliferative GN (N = 20), membrano-proliferative GN (N =
14), IgA-GN (N = 9), membranous GN (N = 8), focal glomeru-
losclerosis (N = 5) and minimal change GN (N = 3).
Clinical recordings of the selected patients included age, sex,
blood pressure, creatinine clearance, and urinalysis with uri-
nary specific gravity performed on a morning urine sample after
an overnight fast. In 15 out of 59 patients, urinary osmolality
(Uosm) had been recorded in addition to specific gravity. In
these 15 patients U0sm was correlated significantly with the
corresponding values of urinary specific gravity (r = 0.962,P <
0.001). Twenty-eight biopsied patients were hypertensive, 31
were normotensive; 16 patients had GFR greater than 90
mi/mm, and in 43 it was lower.
Clearance studies. Clearance studies were performed in 53
patients with GN. None of these patients had significant re-
sidual volume during postmictural cystography, allowing col-
lection of urine by spontaneous voiding. Twelve patients had
normal renal function (inulin clearance greater than 90 mi/mm),
while the remaining 41 had inulin clearance ranging from 15 to
40 ml/min. In all patients, clearance studies were preceded by a
stabilization period during which 24-hr urine collections and
morning blood samples were obtained daily for measurement of
plasma and urinary concentration of sodium, potassium, urea,
and creatinine. The stabilization was considered to be satisfac-
tory when body weight and plasma urea concentration re-
mained constant and the magnitude of changes in creatinine
clearance and urinary excretion of sodium and potassium did
not exceed 10% in 3 consecutive days. Experiments were
performed in the morning with patients in the recumbent
position.
Influence of solute load on urine concentrating ability
Two experiments were performed: (1) To reduce the solute
excretion per nephron, eight normotensive patients (four males
and four females, aged 27 to 63 years) with CRF (inulin
clearance, 20 to 40 mi/mm) were studied during maximal
antidiuresis, first after 1 week at high-sodium (100 mEq/day),
high-protein intake (1.0 g/kg of body wt/day), and then after 1
week of a low-sodium (20 mEq/day), low-protein (0.6 g/kg of
body wt/day) diet. Caloric intake was unchanged (35 Kcal/kg of
body wt/day). Smoke, alcohol, and water were withheld 24 hr
before each study. All the experiments began at the same hour
(9 A.M.) after administration of l-desamino-8-D-arginine vaso-
pressin (DDAVP) (20 g by intranasal route). Inulin (Monico,
Venice, Italy) was infused to maintain 10 to 30 mg% of plasma
inulin concentration. The clearance of inulin (C1) and creati-
nine (Car), and the osmolal clearance (Cosm) and plasma con-
centration of urea and potassium were measured in two con-
secutive 90-mm clearance periods.
(2) To increase acutely the rate of solute excretion, 20
normotensive patients with GN (ten with normal renal function
and ten with CRF) in the same conditions of maximal
antidiuresis as in experiment (1) were loaded with hypertonic
saline (3%), infused at the constant rate of 12 ml/min until the
urine flow rate approximated 25 to 30% of GFR. The infusion
was interrupted whenever blood pressure (recorded every 10
mm) exceeded the value of 150 (systolic) or 100 mm Hg
(diastolic). Blood and urine (for Cr and Csm measurement)
were collected at 20- to 80-mm intervals.
Influence of blood pressure on concentrating and diluting
ability: cross-sectional study
This study was carried out in 15 normotensive and 15
hypertensive patients with CRF and in 12 normotensive pa-
tients with normal GFR. The normotensive and hypertensive
patients with CRF were matched for age, sex, and residual renal
function. In all patients, clearance studies were performed in
maximal antidiuresis (as previously described) and in water
diuresis: The latter was induced by an oral load of water (20
ml/kg of body wt in 30 mm) and maintained by an amount of
water equal to urine output (V) plus 1 mi/mm (to replace
insensible losses). When a steady urine flow was achieved,
three 30-mm clearance periods were performed. The same
clearance measurements as in study (1) were performed.
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Age
Creatinine
clearance
Urine specific
gravity
Renal
arterioloscierosisa
Spearman
rank 0.081 0.519 0.799 0.995
P value NS <0.001 <0.0001 <0.0001
a N = 42.
Influence of blood pressure on concentrating capacity:
longitudinal study
Nine hypertensive patients with CRF (C1, 15 to 40 mI/mm)
were examined in maximal antidiuresis (as previously de-
scribed) before and after 1-month treatment with a beta-
adrenergic blocking agent, propranolol (40 to 120 mg/day). This
drug was chosen as anti-hypertensive medication because it
does not expand ECV [13].
Analytical determinations and calculations
Inulin was determined by the diphenylamine method [14],
creatinine by a creatinine autoanalyzer (Beckman Instruments,
Inc., Fullerton, California, USA), sodium and potassium by a
flame photometer (Beckman Instruments, Inc.), osmolality by
an osmometer (Model 230 D, Fiske Associates, Inc., Uxbridge,
Massachusetts, USA), and urea by the urease method.
C1, Cosm, free-water clearance (CH,o, negative free-water
clearance (TCH2O), and the filtered load of sodium (NaF) were
calculated from standard expressions. The rate of sodium
reabsorption in diluting segments (NaR,dil) was calculated as:
NaR,dil = CH2O X PNa
where PNa is plasma sodium concentration [151.
The delivery of sodium to diluting segments (Na delivery)
was calculated from the expression:
Na delivery = NaR,dil + (UNa + UK) x V
where UNa and UK are urine concentrations of sodium and
potassium, respectively.
Fractional sodium reabsorption in diluting segments
(NaR,dil%) was given by the ratio:
NaR,dil% = NaR,dil < 100
Na delivery
Finally, fractional sodium reabsorption in the proximal tu-
bules (NaR,prox%) was obtained from the expression:
NaF — Na deliveryNaR,prox% = x 100
NaF
The results of the histological study were statistically evalu-
ated by means of nonparametric methods (Wilcoxon's ranking
test and Spearman's rank correlation coefficient) [16]. The
results of clearance studies were evaluated by Student's t test
for paired and unpaired samples.
Table 1. Correlation between renal medullary fibrosis and four
variables in 59 patients with primary chronic glomerulonephritis
Results
Histological studies
The degree of medullary abnormalities was estimated by two
independent observers. Interobserver correlation was highly
significant (P < 0.001), but only the grades of one pathologist
were used for statistical analysis.
As summarized in Table 1, the degree of medullary fibrosis
was correlated inversely with both creatinine clearance and
urine specific gravity and was correlated directly with the
severity of renal arteriolosclerosis. All patients but one with
creatinine clearance below 90 ml/min had moderate to severe
interstitial medullary fibrosis; in the 16 patients with normal
GFR, we could not demonstrate any medullary lesion. Intersti-
tial infiltration with inflammatory cells (mainly monocytes) was
present in 31 out of 43 patients with CCr less than 90 ml/min and
was absent in the 16 patients with Cr greater than 90 mLfmin.
The degree of inflammatory infiltration was correlated with the
degree of medullary fibrosis (r = 0.619, P < 0.001). Tubular
damage was present in 35 out of 43 patients with Cr less than
90 ml/min and in 2 out of 16 patients with Cc1 greater than 90
mI/mm.
The age of the 59 biopsied patients (34 males and 25 females)
ranged from 14 to 69 years with a mean value of 32.5 years.
Medullary fibrosis was significantly more extensive in hyper-
tensive than in normotensive patients (P < 0.001). In the
hypertensive group (N = 28), however, mean C1 was signifi-
cantly lower than in the normotensive group (N = 31). There-
fore, the extent of medullary fibrosis was compared in 23
hypertensive and 21 normotensive patients matched for C1 and
age (Table 2). Renal medullary fibrosis and arteriolar sclerosis
was still significantly different in the two groups.
Finally, in 29 out of 43 patients with Ccr less than 90 ml/min
whose biopsy specimens were studied with immunofluores-
cence, no significant deposition of IgG, 1gM, IgA, C3, C, and
fibrinogen was observed.
(") Clearance studies
Influence of solute load on urine concentrating ability. (1)
Substitution of a low-sodium, low-protein diet for a high-
sodium, high-protein one caused a fall in body weight in 1 week
from 61.1 kg 0.3 SE to 59.9 kg 0.3 SE (P < 0.001) without
(2) changes in BP. As expected, during this period all the patients
showed a cumulative negative sodium balance which averaged
121 mEq. No patient developed symptoms of hypovolemia
during sodium restriction. The data on renal function, solute
excretion and concentrating capacity during maximal anti-
diuresis are shown in Table 3. Restriction of sodium and protein
produced a significant reduction in solute load as reflected by
(3) the decline in plasma concentration (P) and urinay excretion
(Uur x V) of urea, fractional excretion of sodium (FENa and
osmolar clearance. Inulin clearance remained unchanged while
the ratio Uc1/Pc. increased significantly and urine output (V) fell
significantly from 0.99 to 0.55 ml/min. Although the 'obligatory'
(4) solute excretion per nephron was decreased, no significant
modification occurred in maximal urine osmolality (Usm) nor
in the ratio TCH2O/COsm (Table 3).
(2) When solute excretion rate was increased by hypertonic
saline infusion in maximal antidiuresis, urine samples from all
ten patients with CRF became hypotonic (289 to 251 mOsm/kg
H20); in fact, Uosm was 30 to 74 mOsm/kg lower than P0
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Table 2. Differences between normotensive and hypertensive patients with primary chronic glomerulonephritis
Subjects
Medullary fibrosis: Grade Arteriolarsclerosis: Grade Creatinine
clearance
mI/mm
Age
years0 1 2 3 0 1 2 3
Normotensive 10 10
(N=21)
1 — 9 7 1
(N=17)
54
(N=21)
3Ø
(N=21)
Hypertensive — 8
(N = 23)
13 2 3 5 6
(N = 17)
3 M
(N = 23)
35
(N = 23)
P value <0001b <0.OU' NSC NSC
a Mean SE.
b Wilcoxon's ranking test.
Student's t test.
Table 3. Renal function studies during maximal antidiuresis in patients with chronic glomerulonephritis both after a high-sodium and
high-protein diet (H) and after a low-sodium, low-protein diet (L)
C1
mi/mm
V
mi/mm Ur/Pcr
FENA
%
Pur
mg%
Uur X V
mg/mm
Uosm
mOsm/kg 1120
Co,rn
mi/min/dI GFR
T°
X
H20/CO,m
dl GFR
H 32.5 0.99 34.1 1.90 115.4 12.7 441 4.52 1.01
L 31.0 0.55 56.0 0.56 70.1 6.2 420 2.41 0.91
P NS <0.01 <0.005 <0.01 <0.005 <0.01 NS <0.005 NS
Abbreviations: C1,,, inulin clearance; V, urine volume; Ucr, urinary creatinine; Pr,., plasma creatinine; FENA, fractional sodium excretion; Pur,
plasma urea; Uur, urine urea; Uosm, urinary osmolality; Cosm, osmolar clearance; TH2O, free-water reabsorption.
1 2 3 4 5 6 7 8 9 10
Solute excretion for 100 ml of GFR, mOsm/min
Fig. 1. Concentrating capacity of patients, with chronic giomerulone-
phritis with (.) and without (0) CRF at different rates of solutes
excretion.
(mean difference, 48 mOsmlkg). In all ten patients with normal
renal function urine remained hypertonic (404 to 426 mOsmlkg).
During saline infusion no significant change in GFR, evaluated
as Ccr, occurred.
In comparing maximal urine osmolality of normal and dis-
eased kidneys, urine osmolality has to be evaluated at compa-
rable rates of solute excretion per nephron, that is, at equivalent
rates per unit of functioning nephron mass. Therefore, solute
excretion has to be normalized as follows:
Observed rate of solute excretion
x 100 =
In Figure 1, urine osmolalities of patients, studied in the
experimental trials (1) and (2), are plotted against the respective
normalized solute excretion rates. At solute excretion rates less
than 1 mOsm/min for 1 dl of GFR, occurring in (1) during a
low-sodium and low-protein diet, urinary osmolality is mark-
edly lower in patients with CRF than in patients with normal
GFR. This difference in urinary osmolality lasted yet at solute
excretion rates between I and 2 mOsm/min for 1 dl of GFR,
occurring in (1) during a high-sodium and high-protein diet. At
solute excretion rates progressively greater than 2 mOsm/min,
urine osmolality progressively decreases in patients with nor-
mal renal function, reaching a plateau at approximately 400
mOsm/kg H20. In patients with CRF maximal urine osmolality
did not change until about 8 mOsm/min of solute excretion.
Beyond this limit, urine became hypotonic in patients with
CRF, whereas it remained hypertonic in patients with normal
GFR.
Influence of blood pressure on concentrating and diluting
ability: cross-sectional study. At the beginning of clearance
experiments, mean systolic BP was 131.9 4.0 SE mm Hg in
normotensive patients and 179.0 4.0 SE mm Hg in hyperten-
sive patients; mean diastolic BP (5th Korotkoff phase) was 85.5
2.3 SE and 111.0 3.0 mm Hg, respectively. The mean age
was not statistically different between normotensive and hyper-
tensive patients (40.5 2.6 vs. 39.7 2.4). Inulin clearance
ranged between 15 and 40 ml/min in all patients
The data of normotensive and hypertensive patients with
CRF during maximal antidiuresis are shown in Table 4. No
difference was observed in C1, V and urea clearance between
1000
o 900
N
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...• . ••.o °.°..°. o a •0 000000&oo
. .
.. ....
Observed GFR
Solute excretion per dl of GFR
in which the units of the product are mOsm/min.
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Table 4. Renal function studies during maximal antidiuresis in normotensive (N) and hypertensive (H) patients with chronic glomerulonephritis
C1 V Cur Uosm TCH2O TCH2O/COsm
mi/mm mi/mm mi/min/di GFR mOsm/kg Ff20 mi/min/di GFR x dl GFR
N 26.8 0.75 55.0 461 1.50 1.30
H 27,0 0.79 49.9 396 0.88 0.90
P NS NS NS <0.01 <0.0125 <0.05
Abbreviations: Cur, urea clearance; other abbreviations are the same as in Table 1.
Table 5. Renal function studies during maximal water diuresis in normotensive (N) and hypertensive (H) patients with chronic
glomerulonephritis
-- —
C1,, NaF NaR,prox NaDelivery CH2O Cur
mi/mm mEqimin % mEq/mmn mi/min/di GFR mi/min/di GFR
N 24.1 3.13 86.9 0.41 10.3 64.0
H 26.1 3.40 84.7 0.52 9.5 66.6
P NS NS NS <0.05 NS NS
Abbreviations: Na?, the filtered load of sodium; NaR,prox, fractional sodium reabsorption in the proximal tubules; CH2O, free-water generation;
other abbreviations are the same as in Tables 1 and 2.
Table 6. Renal function studies during maximal antidiuresis in patients with chronic glomerulonephritis before (B) and after (A) normalization
of blood pressure
BP
mm Hg
C1,,
mi/mm
V
mi/mm
FENA
%
Uosm
mO.cm/kg H20
Coum
mi/min/di GFR
TCHZO
mi/min/di GFR
B 116 24.5 0.78 1.59 405 4.30 1.09
A 94 25.6 0.76 1.42 409 4.05 1.07
P <0.001 NS NS NS NS NS NS
Abbreviations: BP, mean blood pressure calculated from the diastolic pressure plus one third of the pulse pressure; other abbreviations are the
same as in Table 1.
normotensive and hypertensive patients. Maximal urine
osmolality was significantly lower in hypertensives than in
normotensives; Uosm ranged between 325 and 549 mOsm/kg in
hypertensive patients and between 380 and 699 mOsm/kg in-
normotensive ones. Both TeE20 and TCH2O/COSm per dl of GFR
were lower in hypertensive than in normotensive subjects.
In 12 normotensive subjects with normal GFR, during maxi-
mal antidiuresis, TCH2O per dl of GFR averaged 2.40 0.51
ml/min/dl GFR. This value was significantly greater than in
patients with CRF, both normotensive (1.50 0.21 ml/min/dl
GFR, P < 0.05) and hypertensive (0.88 0.17 ml/min/dl GFR,
P <0.001).
In maximal water diuresis (Table 5), a moderate increase in
NaF in hypertensive patients was associated with a slight
decrease of NaR,ProX resulting in a significantly greater sodium
delivery to the diluting segments in hypertensive than in
normotensive patients. Despite that, free-water generation was
similar in hypertensive as in normotensive patients. During
clearance studies in water diuresis, urine osmolality averaged
125.1 6.0 SE (range, 71.2 to 179.4) and 129.9 6.2 SE (range,
82.0 to 189.6) in normotensive and hypertensive patients,
respectively. These values are the minimum expected in pa-
tients with CRF [17]. Finally, urea clearance was not different
in normotensives and hypertensives.
In 12 normotensive subjects with normal GFR, during maxi-
mal water diuresis, CH2O per dl of GFR averaged 11.5 1.2 SE
mllmin/dl GFR. This value was similar in hypertensive as in
normotensive patients with CRF.
Influence of blood pressure on urine concentrating ability:
longitudinal study. The nine hypertensive patients with CRF
treated with propranolol for 1 month did not show adverse
reactions to the drug nor changes in mean body weight (kg 63.5
2.9 SE before and kg 63.4 2.8 SE after 1 month of therapy).
In all patients blood pressure was restored to normal values
after the first week of therapy. As shown in Table 6, normaliza-
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tion of BP was not associated with any change in C1, urine
Output, FENa, Uosm, Cosm, or Tc112o.
Discussion
It is still uncertain whether the impaired concentrating ability
in CRF is secondary to an intrinsic defect of the diseased kidney
or to a functional adaptation of residual nephrons in the uremic
environment.
In fact, in human studies performed to answer this question,
several limitations have precluded a firm conclusion. First, the
studies [18—22] were carried out both in patients with glomeru-
lar and in patients with nonglomerular nephropathies. It is well
known that primary tubulointerstitial disorders of the kidneys
are associated with a concentrating defect early in the course of
the disease [23]. Second, no effort was done to confirm the
clinical diagnosis of the disease by renal biopsy. Third, no
precaution was used to exclude patients with systemic diseases.
Fourth, the examined patients were frequently in advanced
renal failure. Under such circumstances, high rates of solute
excretion per nephron are common. Thus, even severe restric-
tions of sodium intake [22] are unable to lower solute excretion
below 1 mOsm/min per dl of GFR [20, 22], that is, the
physiologic range of solute excretion. Fifth, no attempt was
done to distinguish between normotensive and hypertensive
patients. In the hypertensive subject, sodium transport is im-
paired in Henle's loop [24] and this alters urinary concentration
[25]. Finally, both patients and control normal subjects were
studied as outpatients [20, 221 so that careful precautions could
not be used to achieve and maintain a steady state condition
before performing renal clearance studies. Moreover, the con-
trol groups of presently available studies [20—22] were not
appropriate, consisting of subjects without any renal disease;
patients with comparable renal lesions but with a normal GFR
would provide a more valuable control.
In this study retrospective investigations have shown clearly
that a medullary interstitial fibrosis of various degree is usual in
primary glomerular diseases with mild to moderate CRF; the
histological damage of the interstitial medullary tissue is pro-
portional with the impairment in renal concentrating ability.
Disproportionate destruction of long-looped nephrons, altera-
tion of medullary circulation, and delayed diffusion of solute
because of inflammatory infiltrates and scars in the renal
medulla may well account for the defective concentrating
process. Other authors [26] have already demonstrated a sig-
nificant correlation of the impaired concentrating ability with
interstitial lesions, but in their studies the renal tissue speci-
mens were represented by renal cortex only.
We have also observed a significant relation of renal medul-
lary fibrosis with arteriolosclerosis and hypertension (Tables 1
and 2). The more pronounced medullary fibrosis in hyperten-
sive patients is probably secondary to the higher degree of renal
arteriolosclerosis and the consequent medullary ischemia.
These findings are consistent with the results of Haggitt, Pitcok,
and Muirhead [12] on 100 autopsies of unselected patients; the
authors, however, did not report on the underlying disease, the
renal function, and the urinary concentrating ability of the
patients before death.
The possible influence of uremic environment in determining
the concentrating defect has been investigated by clearance
studies. One week of low-protein, low-sodium diet was suf-
ficient to reduce the filtered load of urea by 40% and to
normalize fractional sodium excretion. The resulting decrease
in osmolar clearance was not associated with a fall in GFR nor
in BP as reported by others [27, 28]. The U/Pc.. ratio increased
and urine output fell, indicating greater reabsorption of tubular
fluid in the proximal tubules resulting from a reduction in both
ECV expansion (as shown by the decrease in body weight) and
the osmotic load of urea. Despite the reduction in tubular flow
rate and solute excretion per nephron, however, the maximal
urinary osmolality did not increase (Table 3). Clearly, the
persistent defect in urinary concentrating ability was not due to
a failure of low-sodium, low-protein diet to lower solute excre-
tion rates to the normal range. In fact, Usm did not increase
even if solute excretion rate fell below 1 mOsm/min, that is, the
approximate limit in hydropenic patients with normal GFR
(before saline infusion, Fig. 1).
A possible objection is that the reduction in dietary protein
and sodium intake may have impaired the ability of the kidney
to concentrate urine, thus blunting the improvement in urine
concentration. This defect, however, is usually observed during
chronic malnutrition [29] or after severe protein and sodium
restriction [30, 31] and is commonly associated with a fall in
GFR. In our patients, protein and sodium restriction was
moderate, lasted only 1 week and did not result in any fall in
GFR. Furthermore, even with the same solute excretion rate
occurring in patients with CRF at high sodium and protein
intake (1.0 to 1.9 mOsm/min per dl of GFR), normal subjects
were able to concentrate urine (Fig. 1). These results clearly
indicate that the impaired maximal urinary osmolality in CRF
does not depend on solute load.
When urinary solute excretion was increased by hypertonic
saline infusion, the maximal urine osmolality decreased pro-
gressively, approaching isotonicity in patients with normal GFR
(Fig. 1). This is a well-known phenomenon demonstrating that
the solute load is responsible for a concentrating defect in
normal subjects [7]. In contrast, in patients with CRF maximal
urine osmolalities did not change until about 8 mOsmlmin of
solute excretion. Beyond this limit, urine became hypotonic in
patients with CRF despite the administration of pharmacologi-
cal doses of DDAVP, whereas it remained hypertonic in pa-
tients with normal GFR. There is only one possible explanation
for this phenomenon, that is, the free-water generated in the
diluting segments was reabsorbed incompletely distally in the
nephron. Since this phenomenon did not occur at similar flow
rates (per unit of GFR) in normal subjects, this must mean that
the nephron beyond the diluting segment (that is, the distal
tubule and/or collecting duct) was less permeable to water in
CRF. This observation indicates that the increased saline
diuresis in CRF can unmask a state of incomplete nephrogenic
diabetes rather than represent a critical pathogenetic factor in
leading to hypotonic urine.
Consistent with this conclusion are microperfusion studies of
isolated nephrons of uremic rabbits, which have demonstrated
a reduced permeability of collecting ducts to water, even in the
presence of ADH [32]. Furthermore, a vasopressin-resistant
hyposthenuria was observed by Tannen et al [33] in patients
with far-advanced CRF. Our results indicate that a reduced
water permeability in the distal nephron is obtained even in
patients with mild to moderate CRF at very high rates of solute
excretion. Since urea reabsorption in the medullary collecting
798 Conte et al
duct depends on water reabsorption, the resulting impairment
in urea recycling may contribute in reducing medullary
hypertonicity.
The impairment in the concentrating ability was greater in
hypertensive patients and was not reversed by normalization of
BP (Tables 4 and 6). These results suggest that the enhanced
defect in concentrating mechanism in hypertensive patients
with CRF does not depend on increased perfusion pressure but
is secondary to an intrinsic lesion of the kidneys. This observa-
tion is consistent with the greater degree of medullary fibrosis
observed in hypertensive patients in our histological studies
(Table 2).
Finally, impaired sodium chloride transport out of the thick
ascending limb of Henle's loop does not appear to play an
important role in the concentrating defect. In fact, during
maximal water diuresis, free-water generation in the diluting
segments (per unit of GFR), which depends on chloride and
sodium transport in the Henle's loop, remained similar both in
patients with CRF and normal GFR. Such a preserved diluting
ability was associated with an inability to reabsorb free-water
distally. One possible explanation for this finding is the exist-
ence of an impaired permeability of collecting duct to water in
CRF.
In conclusion, although mechanisms underlying the observed
phenomena have not been exactly identified, our study gives
evidence that neither the increased filtered load of urea nor the
ECV expansion play a critical role in reducing the concentrating
ability in CRF. The concentrating defect is better accounted for
by an intrinsic medullary damage, which is highly enhanced in
hypertensive patients. The vasopressin-resistant hyposthenuria
induced by hypertonic saline infusion suggests that an impaired
permeability of collecting ducts to water may result from
medullary damage.
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